154 related articles for article (PubMed ID: 33960553)
1. Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients.
Hoesseini A; van Leeuwen N; Offerman MPJ; Zhang J; Dronkers EAC; Sewnaik A; Lingsma HF; Baatenburg de Jong RJ
Head Neck; 2021 Aug; 43(8):2445-2456. PubMed ID: 33960553
[TBL] [Abstract][Full Text] [Related]
2. Prognostic model for overall survival of head and neck cancer patients in the palliative phase.
Hoesseini A; Sewnaik A; van den Besselaar BN; Zhang J; van Leeuwen N; Hardillo JA; Baatenburg de Jong RJ; Offerman MPJ
BMC Palliat Care; 2024 Feb; 23(1):54. PubMed ID: 38395897
[TBL] [Abstract][Full Text] [Related]
3. Impact of a prognostic model for overall survival on the decision-making process in a head and neck cancer multidisciplinary consultation meeting.
Dorr MC; Hoesseini A; Sewnaik A; Hardillo JA; Baatenburg de Jong RJ; Offerman MPJ
Head Neck; 2022 Nov; 44(11):2481-2490. PubMed ID: 35906922
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
Rühle A; Stromberger C; Haehl E; Senger C; David H; Stoian R; Zamboglou C; Knopf A; Budach V; Grosu AL; Nicolay NH
Radiother Oncol; 2021 Jan; 154():276-282. PubMed ID: 33245947
[TBL] [Abstract][Full Text] [Related]
5. Update and external validation of a head and neck cancer prognostic model.
Datema FR; Ferrier MB; Vergouwe Y; Moya A; Molenaar J; Piccirillo JF; Baatenburg de Jong RJ
Head Neck; 2013 Sep; 35(9):1232-7. PubMed ID: 22847987
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients.
Qian X; Nguyen DT; Dong Y; Sinikovic B; Kaufmann AM; Myers JN; Albers AE; Graviss EA
Int J Biol Sci; 2019; 15(7):1336-1344. PubMed ID: 31337965
[TBL] [Abstract][Full Text] [Related]
7. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
8. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
[TBL] [Abstract][Full Text] [Related]
9. Prognostic nomograms based on immune scores for head-neck squamous cell carcinoma patients.
Li W; Zhao K; Wang Z
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2493-2500. PubMed ID: 33068170
[TBL] [Abstract][Full Text] [Related]
10. Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma.
Maebayashi T; Ishibashi N; Aizawa T; Sakaguchi M; Saito T; Kawamori J; Tanaka Y; Hirotani Y; Homma T
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1221-1229. PubMed ID: 30756227
[TBL] [Abstract][Full Text] [Related]
11. Head and neck cancer patients' preferences for individualized prognostic information: a focus group study.
Hoesseini A; Dronkers EAC; Sewnaik A; Hardillo JAU; Baatenburg de Jong RJ; Offerman MPJ
BMC Cancer; 2020 May; 20(1):399. PubMed ID: 32380962
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
13. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
14. Incremental Prognostic Value of Apparent Diffusion Coefficient Histogram Analysis in Head and Neck Squamous Cell Carcinoma.
Li X; Yuan Y; Ren J; Shi Y; Tao X
Acad Radiol; 2018 Nov; 25(11):1433-1438. PubMed ID: 29599009
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
17. Outcome prediction models incorporating clinical variables for Head and Neck Squamous cell Carcinoma: A systematic review of methodological conduct and risk of bias.
Aly F; Hansen CR; Al Mouiee D; Sundaresan P; Haidar A; Vinod S; Holloway L
Radiother Oncol; 2023 Jun; 183():109629. PubMed ID: 36934895
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in N3 Head and Neck Squamous Cell Carcinoma and Role of Upfront Neck Dissection.
Boros A; Blanchard P; Dade A; Gorphe P; Breuskin I; Even C; Nguyen F; Deutsch E; Bidault F; Janot F; Temam S; Mirghani H; Tao Y
Laryngoscope; 2021 Mar; 131(3):E846-E850. PubMed ID: 32833260
[TBL] [Abstract][Full Text] [Related]
20. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
Chandrasekara S; Davis S; Thomson P; Haydon A
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]